Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
Journal of Advanced Nursing
|
October 2, 2024
Integrated Health Education Programmes With Physical Activity Among Community-Dwelling Older Adults at Risk of Atherosclerotic Cardiovascular Disease: An Integrative Review of Experimental Studies
Flora M W Lo, Eliza M L Wong, Katherine Ka Wai Lam, et al.
Clinical Pharmacology and Therapeutics
|
March 30, 1999
Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174
J B McCrea, A Cribb, T Rushmore, et al.
Journal of Clinical Pharmacology
|
July 3, 1998
Pharmacokinetics of intravenous and oral losartan in patients with heart failure
M W Lo, J Toh, S E Emmert, et al.
Journal of Clinical Pharmacology
|
October 5, 2001
The pharmacokinetics of enalapril in children and infants with hypertension
T Wells, R Rippley, R Hogg, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1997
DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan
M R Goldberg, M W Lo, D D Christ, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
July 1, 1995
The pharmacokinetics of losartan in renal insufficiency
D A Sica, M W Lo, W C Shaw, et al.
Kidney International
|
March 29, 2026
A prospective multi-center randomized controlled trial preemptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission
Desmond Y H Yap, Shirley C W Chan, Patrick Y H Wong, et al.
Journal of Clinical Pharmacology
|
June 27, 2000
PhRMA perspective on population and individual bioequivalence
J S Barrett, V Batra, A Chow, et al.
Journal of Clinical Pharmacology
|
June 27, 2000
Update to the PhRMA perspective on population and individual bioequivalence
J S Barrett, V Batra, A Chow, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
June 5, 2009
Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection
S K Mak, K Y Lo, M W Lo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
Journal of Advanced Nursing
|
October 2, 2024
Integrated Health Education Programmes With Physical Activity Among Community-Dwelling Older Adults at Risk of Atherosclerotic Cardiovascular Disease: An Integrative Review of Experimental Studies
Flora M W Lo, Eliza M L Wong, Katherine Ka Wai Lam, et al.
Clinical Pharmacology and Therapeutics
|
March 30, 1999
Phenotypic and genotypic investigations of a healthy volunteer deficient in the conversion of losartan to its active metabolite E-3174
J B McCrea, A Cribb, T Rushmore, et al.
Journal of Clinical Pharmacology
|
July 3, 1998
Pharmacokinetics of intravenous and oral losartan in patients with heart failure
M W Lo, J Toh, S E Emmert, et al.
Journal of Clinical Pharmacology
|
October 5, 2001
The pharmacokinetics of enalapril in children and infants with hypertension
T Wells, R Rippley, R Hogg, et al.
Clinical Pharmacology and Therapeutics
|
January 1, 1997
DuP 532, an angiotensin II receptor antagonist: first administration and comparison with losartan
M R Goldberg, M W Lo, D D Christ, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
July 1, 1995
The pharmacokinetics of losartan in renal insufficiency
D A Sica, M W Lo, W C Shaw, et al.
Kidney International
|
March 29, 2026
A prospective multi-center randomized controlled trial preemptive increase in immunosuppression for asymptomatic serological reactivation in patients with lupus nephritis in clinical remission
Desmond Y H Yap, Shirley C W Chan, Patrick Y H Wong, et al.
Journal of Clinical Pharmacology
|
June 27, 2000
PhRMA perspective on population and individual bioequivalence
J S Barrett, V Batra, A Chow, et al.
Journal of Clinical Pharmacology
|
June 27, 2000
Update to the PhRMA perspective on population and individual bioequivalence
J S Barrett, V Batra, A Chow, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi
|
June 5, 2009
Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection
S K Mak, K Y Lo, M W Lo, et al.
Page
of 5